Evidence map›Paper›PMID 11250737›Full record

ReviewBreast cancer research : BCR2000

Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.

S E Clare, F Nakhlis, J C Panetta

Abstract readComparative StudyReview
In one paragraph

Review in Breast cancer research : BCR, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Modeling drug resistance in a conjoint normal-tumor setting.Theoretical biology & medical modelling · 2015
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. The dynamics of drug resistance: a mathematical perspective.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

S E ClareDepartment of Surgery, Northwestern University Medical School, Northwestern Memorial Hospital, Chicago, Illinois 60611-3010, USA. sclare@nmff.nwu.edu
F Nakhlis
J C Panetta

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer mortality rates have shown only modest improvement despite the advent of effective chemotherapeutic agents which have been administered to a large percentage of women with breast cancer. In an effort to improve breast cancer treatment strategies, a variety of mathematical models have been developed that describe the natural history of breast cancer and the effects of treatment on the cancer. These models help researchers to develop, quantify, and test various treatment hypotheses quickly and efficiently. The present review discusses several of these models, with a focus on how they have been used to predict the initiation time of metastatic growth, the effect of operative therapy on the growth of metastases, and the optimal administration strategy for chemotherapy.

Indexed as

Models, BiologicalNeoplasm MetastasisAlgorithmsAngiogenesis InhibitorsAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCell DivisionChemotherapy, AdjuvantClinical Trials as TopicCombined Modality TherapyDisease ProgressionDrug Administration ScheduleDrug Resistance, NeoplasmFemaleHumansMastectomyAngiogenesis Inhibitors

Identifiers

PMID11250737
PMCPMC138666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.